中国医药

- 600056

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
中国医药(600056) 利润表
单位:万元
报表日期2024-09-302024-06-302024-03-312023-12-312023-09-30
一、营业总收入2,609,973.001,779,732.22877,484.593,882,443.052,979,676.75
营业收入2,609,973.001,779,732.22877,484.593,882,443.052,979,676.75
二、营业总成本2,521,678.361,715,329.11851,387.643,750,189.512,868,495.19
营业成本2,331,705.861,585,603.33787,133.413,444,081.372,649,590.26
营业税金及附加6,875.394,594.442,294.1212,740.259,563.95
销售费用83,616.4758,938.6730,264.94161,089.95121,001.37
管理费用77,749.1450,953.9924,079.03109,520.3874,269.05
财务费用12,756.218,870.404,366.8911,203.826,722.95
研发费用8,975.296,368.273,249.2511,553.737,347.62
资产减值损失----------
公允价值变动收益-110.85-110.85-44.3198.4933.43
投资收益500.27131.06365.17-1,579.222,781.84
其中:对联营企业和合营企业的投资收益3,514.932,314.931,090.537,704.316,571.37
汇兑收益----------
三、营业利润85,056.4760,665.2727,553.22167,233.42110,548.89
加:营业外收入976.64671.8492.332,541.881,469.64
减:营业外支出1,754.73934.73288.945,719.751,103.48
其中:非流动资产处置损失----------
四、利润总额84,278.3860,402.3827,356.61164,055.55110,915.05
减:所得税费用22,186.5815,426.717,068.5339,843.5132,548.77
五、净利润62,091.8044,975.6820,288.08124,212.0578,366.28
归属于母公司所有者的净利润44,714.8332,511.9014,560.00104,803.9159,411.06
少数股东损益17,376.9712,463.775,728.0919,408.1318,955.22
六、每股收益
基本每股收益(元/股)0.29890.21730.09730.70060.3972
稀释每股收益(元/股)0.29890.21730.09730.70060.3972
七、其他综合收益-354.53-145.72136.15-4,068.6670.66
八、综合收益总额61,737.2744,829.9620,424.23120,143.3878,436.94
归属于母公司所有者的综合收益总额44,360.3132,366.1914,696.14100,733.9159,481.72
归属于少数股东的综合收益总额17,376.9712,463.775,728.0919,409.4818,955.22
下载全部历史数据到excel中 返回页顶